Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
COOP
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
IPG
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.91% |
| 4 | Healthcare | 9.83% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Heart Test Laboratories
HSCS
$8.03M
| $57.3K | ﹤0.01% |
18,556
| – | – |
|
|
ULY
4227
DELISTED
Urgent.ly
ULY
| $57K | ﹤0.01% |
19,504
| – | – |
|
4228
Mustang Bio
MBIO
$4.32M
| $56.8K | ﹤0.01% |
57,863
| – | – |
|
|
ASBP
4229
Aspire Biopharma
ASBP
$9.34M
| $56.6K | ﹤0.01% |
357
| – | – |
|
|
FOXX
4230
Foxx Development Holdings
FOXX
$19.4M
| $56.1K | ﹤0.01% |
12,100
| – | – |
|
4231
Bolt Biotherapeutics
BOLT
$7.32M
| $55.8K | ﹤0.01% |
10,179
-24,052
| -70% | -$129K |
|
4232
Greenlane Holdings
GNLN
$1.33M
| $55.4K | ﹤0.01% |
4,414
+3,131
| +244% | +$79.4K |
|
4233
Edesa Biotech
EDSA
$54.5M
| $54.5K | ﹤0.01% |
37,600
-7,943
| -17% | -$15.6K |
|
4234
PharmaCyte Biotech
PMCB
$6.49M
| $54.2K | ﹤0.01% |
74,919
| – | – |
|
|
STAI
4235
DELISTED
ScanTech AI Systems
STAI
| $54.1K | ﹤0.01% |
21,986
-2
| -0% | -$16 |
|
|
DAIC
4236
CID HoldCo Inc
DAIC
$1.69M
| $53.8K | ﹤0.01% |
4,793
+209
| +5% | +$10.8K |
|
4237
Theriva Biologics
TOVX
$9.96M
| $53.7K | ﹤0.01% |
255,727
+239,345
| +1,461% | +$70.8K |
|
4238
Generation Income Properties
GIPR
$765K
| $53.6K | ﹤0.01% |
8,473
| – | – |
|
4239
Yunhong Green CTI Ltd
YHGJ
$7.65M
| $53.5K | ﹤0.01% |
14,816
-1
| -0% | -$5 |
|
4240
Biomerica
BMRA
$4.94M
| $53.2K | ﹤0.01% |
21,127
| – | – |
|
|
TWAV
4241
TaoWeave Inc
TWAV
$4.35M
| $53K | ﹤0.01% |
29,294
| – | – |
|
4242
Astrotech Corp
ASTC
$15.2M
| $52.9K | ﹤0.01% |
14,774
| – | – |
|
4243
Moleculin Biotech
MBRX
$14.7M
| $51.5K | ﹤0.01% |
15,544
+5,947
| +62% | +$55.4K |
|
|
LPA
4244
Logistic Properties of the Americas
LPA
$91.7M
| $51.3K | ﹤0.01% |
18,801
+652
| +4% | +$2.2K |
|
4245
Healthcare Triangle
HCTI
$3.47M
| $50.9K | ﹤0.01% |
1,340
| – | – |
|
4246
Creative Medical Technology
CELZ
$5.26M
| $50.7K | ﹤0.01% |
25,868
| – | – |
|
4247
KALA BIO
KALA
$11.3M
| $50.6K | ﹤0.01% |
1,820
-2,397
| -57% | -$107K |
|
4248
Aprea Therapeutics
APRE
$7.81M
| $49.5K | ﹤0.01% |
58,086
-100,152
| -63% | -$123K |
|
4249
Avalon Holdings
AWX
$9.94M
| $49.5K | ﹤0.01% |
18,392
+2,892
| +19% | +$7.86K |
|
|
PMI
4250
Picard Medical
PMI
$9.03M
| $49.3K | ﹤0.01% |
+28,145
| New | +$132K |
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4%. Vanguard Group opened 82 new positions and exited 97, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 97 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.